Product Information
CLINDAMYCIN PHOS 1% PLEDGET is a generic product labeled by Padagis Israel Pharmaceuticals Ltd, priced at $0.2881 per EA under NDC 45802026337. Its NADAC has been published 657 times since Nov 28, 2013.
Strength
10 mg/mL
Manufacturer
Padagis Israel Pharmaceuticals LtdNDC
45802026337
Classification
Generic
Dosage Form
SOLUTION
Route
TOPICAL
Last Updated
6/17/2026
Active Ingredients
CLINDAMYCIN PHOSPHATEApproval Type
Generic (ANDA)
FDA Application
ANDA065049On Market Since
5/31/2006
Pharmacological Classes
Price Statistics
The NADAC for CLINDAMYCIN PHOS 1% PLEDGET has been published 657 times since Nov 28, 2013, and over the history we have for it it has declined 18.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2881 per EA |
|---|---|
| All-time high | $0.4288 (Feb 16, 2022) |
| All-time low | $0.2781 (Feb 18, 2026) |
| 52-week high | $0.3145 |
| 52-week low | $0.2781 |
| Median price | $0.3259 |
| Average price | $0.3304 |
| Largest weekly change | +41.4% (Jan 19, 2022) |
| Weeks tracked | 657 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the Clindamycin Phosphate market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of CLINDAMYCIN PHOS 1% PLEDGET?
The current National Average Drug Acquisition Cost (NADAC) for CLINDAMYCIN PHOS 1% PLEDGET, manufactured by Padagis Israel Pharmaceuticals Ltd, is $0.2881 per EA (NDC 45802026337), effective Jun 24, 2026.
How has the price of CLINDAMYCIN PHOS 1% PLEDGET changed over time?
Over the history we have for it, the NADAC for CLINDAMYCIN PHOS 1% PLEDGET has declined 18.4%. It has been tracked across 657 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for CLINDAMYCIN PHOS 1% PLEDGET?
Since Nov 28, 2013, the NADAC for CLINDAMYCIN PHOS 1% PLEDGET has ranged from a low of $0.2781 (Feb 18, 2026) to a high of $0.4288 (Feb 16, 2022), with a median of $0.3259 per EA.
Are there cheaper alternatives to CLINDAMYCIN PHOS 1% PLEDGET?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of CLINDAMYCIN PHOS 1% PLEDGET, so no direct lower-cost alternative is listed.
Who manufactures CLINDAMYCIN PHOS 1% PLEDGET?
CLINDAMYCIN PHOS 1% PLEDGET (NDC 45802026337) is labeled by Padagis Israel Pharmaceuticals Ltd, and CMS classifies it as a generic product.
Related Drugs
Same classification